All News #Library
Rare Diseases
iOnctura starts Phase II study in metastatic uveal melanoma
20 Mar 2025 //
PR NEWSWIRE
US FDA grants Orphan Drug Designation for iOnctura`s autotaxin cancer therapy
07 Mar 2024 //
PR NEWSWIRE

Market Place
Sourcing Support